Euromedis Groupe Past Earnings Performance
Past criteria checks 0/6
Euromedis Groupe's earnings have been declining at an average annual rate of -25.1%, while the Medical Equipment industry saw earnings growing at 2% annually. Revenues have been declining at an average rate of 40% per year.
Key information
-25.1%
Earnings growth rate
-363.0%
EPS growth rate
| Medical Equipment Industry Growth | 4.3% |
| Revenue growth rate | -40.0% |
| Return on equity | -18.9% |
| Net Margin | -11.1% |
| Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Euromedis Groupe makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 50 | -6 | 22 | 0 |
| 31 Mar 23 | 52 | -6 | 24 | 0 |
| 31 Dec 22 | 54 | -6 | 25 | 0 |
| 30 Sep 22 | 62 | -7 | 26 | 0 |
| 30 Jun 22 | 69 | -8 | 26 | 0 |
| 31 Mar 22 | 91 | -3 | 27 | 0 |
| 31 Dec 21 | 112 | 2 | 27 | 0 |
| 30 Sep 21 | 158 | 13 | 28 | 0 |
| 30 Jun 21 | 204 | 23 | 29 | 0 |
| 31 Mar 21 | 199 | 23 | 29 | 0 |
| 31 Dec 20 | 193 | 23 | 28 | 0 |
| 30 Sep 20 | 147 | 12 | 28 | 0 |
| 30 Jun 20 | 100 | 0 | 27 | 0 |
| 31 Mar 20 | 89 | -2 | 27 | 0 |
| 31 Dec 19 | 77 | -4 | 28 | 0 |
| 31 Dec 18 | 76 | -5 | 26 | 0 |
| 31 Jan 18 | 76 | -1 | 32 | 0 |
| 31 Oct 17 | 75 | -1 | 29 | 0 |
| 31 Jul 17 | 74 | 0 | 25 | 0 |
| 30 Apr 17 | 74 | 1 | 18 | 0 |
| 31 Jan 17 | 74 | 1 | 11 | 0 |
| 31 Oct 16 | 74 | 1 | 12 | 0 |
| 31 Jul 16 | 74 | 1 | 12 | 0 |
| 30 Apr 16 | 73 | 2 | 12 | 0 |
| 31 Jan 16 | 72 | 2 | 12 | 0 |
| 31 Oct 15 | 72 | 2 | 12 | 0 |
| 31 Jul 15 | 72 | 2 | 11 | 0 |
| 30 Apr 15 | 71 | 2 | 11 | 0 |
| 31 Jan 15 | 71 | 2 | 11 | 0 |
| 31 Oct 14 | 72 | 2 | 11 | 0 |
| 31 Jul 14 | 72 | 3 | 11 | 0 |
| 30 Apr 14 | 74 | 3 | 11 | 0 |
| 31 Jan 14 | 75 | 2 | 11 | 0 |
| 31 Oct 13 | 76 | 2 | 11 | 0 |
| 31 Jul 13 | 76 | 2 | 11 | 0 |
| 30 Apr 13 | 76 | 2 | 11 | 0 |
Quality Earnings: 61R is currently unprofitable.
Growing Profit Margin: 61R is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 61R is unprofitable, and losses have increased over the past 5 years at a rate of 25.1% per year.
Accelerating Growth: Unable to compare 61R's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 61R is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-9.8%).
Return on Equity
High ROE: 61R has a negative Return on Equity (-18.89%), as it is currently unprofitable.